financetom
Business
financetom
/
Business
/
RTX Lands $529M Contract To Bolster Dutch Missile Defense: Details
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RTX Lands $529M Contract To Bolster Dutch Missile Defense: Details
Jan 16, 2025 8:46 AM

RTX Corporation ( RTX ) shares are largely flat on Thursday, following the announcement of a $529 million contract to supply the Netherlands with a Patriot air and missile defense system.

The contract will provide the country with a complete fire unit, including radar, launchers, command and control stations, and other support equipment.

This order comes as part of the Netherlands’ efforts to replenish a Patriot unit donated to Ukraine.

“Raytheon is committed to partnering with the Dutch as they continue to advance their integrated air and missile defense capabilities,” said Pete Bata, senior vice president of Global Patriot at Raytheon.

“The Netherlands’ investment in Patriot ensures collective security and deterrence across Europe,” Bata adds.

Also Read: Netanyahu Postpones Ceasefire Vote, Raising Questions About Gaza Truce Prospects

Patriot systems are considered the world’s most advanced and proven air defense solution, capable of defending against a wide range of aerial threats, including long-range cruise missiles and tactical ballistic missiles.

Meanwhile, analyst Seth M. Seifman has reaffirmed RTX as a top pick for 2025.

He sees the company’s growth potential and margin expansion across its business segments.

With an optimistic outlook on free cash flow, Seifman remains bullish on RTX’s long-term prospects, favoring it over competitors in the aerospace and defense industry.

According to Benzinga Pro, RTX stock has gained over 40% in the past year. Investors can gain exposure to the stock via iShares U.S. Aerospace & Defense ETF ( ITA ) .

Price Action: RTX shares are trading higher by 0.539% to $119.72 at last check Thursday.

Read Next:

Biden’s Farewell Address Targets Tech Oligarchy In Trump 2.0 Era: President Says Americans Face ‘Avalanche Of Misinformation’

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Market Chatter: BlackRock Dropped Ukraine Fund Talks Following Trump's Election as President
Market Chatter: BlackRock Dropped Ukraine Fund Talks Following Trump's Election as President
Jul 7, 2025
08:02 AM EDT, 07/07/2025 (MT Newswires) -- BlackRock ( BLK ) dropped talks with potential investors for the Ukraine Development Fund earlier this year, as US President Donald Trump took office and clashed with Ukrainian President Volodymyr Zelenskiy and Russian President Vladimir Putin, Bloomberg News reported Saturday, citing sources familiar with the matter. Bloomberg said Trump's election campaign included a...
Mercedes-Benz Q2 sales fall 9% impacted by tariffs
Mercedes-Benz Q2 sales fall 9% impacted by tariffs
Jul 7, 2025
(Reuters) -German carmaker Mercedes-Benz said on Monday its second-quarter unit sales of cars and vans fell 9%, citing the impact of tariffs. Deliveries fell to 547,100 cars and vans in the April-June period, while sales of battery electric vehicles dropped even more sharply by 18%, to 41,900 vehicles, the company said in a statement. Second-quarter sales of Mercedes' Cars unit...
Nurix Says Blood Cancer Therapy Bexobrutideg Gets European Orphan Drug Designation
Nurix Says Blood Cancer Therapy Bexobrutideg Gets European Orphan Drug Designation
Jul 7, 2025
08:04 AM EDT, 07/07/2025 (MT Newswires) -- Nurix Therapeutics ( NRIX ) said Monday that the European Medicines Agency has granted orphan drug designation to bexobrutideg, a treatment for Waldenstrom macroglobulinemia, or WM, a rare type of blood cancer. Bexobrutideg is currently being evaluated in a phase 1 clinical trial in patients with relapsed or refractory B-cell malignancies, including WM....
Copyright 2023-2026 - www.financetom.com All Rights Reserved